ABSTRACT. Allyl isothiocyanate (AITC), a metabolite of the glucosinolate sinigrin, protects the liver of rats injured by carbon tetrachloride (CCl 4 ). This study evaluated whether AITC reduces hepatic fibrosis in rats repetitively exposed to CCl 4 . Serum chemistry showed that AITC (doses of 5 and 50 mg) administered to rats exposed to CCl 4 significantly reduced the levels of alanine aminotransferase and aspartate aminotransferase activity that were elevated in CCl 4 -intoxicated rats. The connective tissue in AITC-treated rats was significantly reduced based on Sirius staining. In addition, Kupffer cell activation was significantly reduced in the AITC and CCl 4 co-treated groups. Collectively, this study suggests that AITC mitigates hepatic fibrosis in rats repetitively exposed to CCl 4 with concurrent regulation of Kupffer cell and monocyte activation.
immunohistochemistry. In addition, Sirius Red (Direct Red 80, Cat. 365548; Sigma-Aldrich) staining was performed for fibrillar collagen. We subjected fixed frozen sections to Oil-Red-O staining to reveal fatty changes.
Blood samples (n=5 animals per group) were allowed to coagulate at room temperature and were centrifuged (3,000 rpm, 10 min, room temperature), and the serum fraction was collected. The serum levels of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) were detected using a FUJI DRI-CHEM 4200 system (FUJIFILM, Tokyo, Japan).
To evaluate Kupffer cell and macrophage activation in hepatic tissue, immunohistochemistry using rabbit anti-ionized calcium binding protein-1 (Iba-1, 1 µg/ml; Cat. 019-19741, Lot. LKH4161; Wako Pure Chemical Industries, Ltd., Osaka, Japan) was performed in liver tissue using the VECTASTAIN ABC Elite Kit (Vector Labs, Burlingame, CA, U.S.A.), as described previously [2] . Quantitative analysis of Iba-1-immunostained areas (centrilobular regions) and Sirius Red-stained areas (n=3 animals per group) were performed with the aid of ImageJ software (NIH, Bethesda, MD, U.S.A.). At least five regions of each liver section were photographed. The Iba-1-and Sirius Red-positive area [(positive area/total area) ×100 (%)] were shown as the mean ± standard error of the mean (SEM). In addition, we counted the number of Iba-1-positive cells in 5 different centilobular regions of each liver section (n=3 animals per group). Data were subjected to one-way analysis of variance followed by the Student-Newman-Keuls post hoc test for multiple comparisons. In all cases, P values <0.05 were considered to indicate statistical significance.
To evaluate the effect of AITC on CCl 4 -induced liver injury, we performed a serum chemistry analysis, including of AST and ALT levels ( Table 1 ). The AST and ALT levels in the AITC50 group were within the normal range (AST, 328.38 ± 17.93; ALT, 62.18 ± 7.45). Both AST (1,691.9 ± 190.27) and ALT (1,766.17 ± 157.81) levels in the vehicle + CCl 4 group were significantly increased compared with the normal control group (315 ± 22.82, 54.98 ± 5.1, P<0.001). However, the ALT level (1,118.7 ± 157.67) in the AITC5 + CCl 4 group was significantly reduced (P<0.05 vs. vehicle + CCl 4 group). Furthermore, the AITC50 + CCl 4 group showed a significant decrease in both AST (917.45 ± 237.05, P<0.05) and ALT (235.37 ± 55.45, P<0.001) levels compared with the vehicle + CCl 4 group. These results suggest that AITC has an ameliorative effect on CCl 4 -induced liver injury.
In the normal control group, the liver tissue exhibited a regular arrangement of hepatocytes and no cytopathogenic changes (Fig. 1A) . Meanwhile, the livers of rats in the vehicle + CCl 4 group showed extensive hydropic degeneration (arrows), vacuolar degeneration (arrowheads), necrosis (hollow arrowheads), and infiltration of inflammatory cells (hollow arrows) (Fig. 1B) . Compared with the liver tissue of the vehicle + CCl 4 group, the hepatic damage in the AITC5 and AITC50 + CCl 4 groups was reduced ( Fig. 1C and 1D ). Oil-Red-O staining, which measures fatty changes, confirmed that AITC mitigated the histopathological changes in the liver caused by CCl 4 -induced injury.
To evaluate the effect of AITC treatment on hepatic fibrosis in CCl 4 -induced liver injury, we performed Sirius Red staining. In the normal control group, Sirius Red-positive collagen fibers were detected around the portal triad regions (Fig. 2A) . However, collagen tissue proliferation by fibrosis was observed in the livers of CCl 4 -injured rats (Fig. 2B) . AITC treatment reduced the increase in collagen tissue proliferation ( Fig. 2C and 2D ), compared with the CCl 4 -injured rat liver tissue. The quantitative analysis of the Sirius Red-positive area using ImageJ confirmed the histopathological findings. In the vehicle + CCl 4 group, the Sirius Redpositive area was significantly increased (8.62 ± 0.3%, P<0.001) compared with that of the normal control group. The AITC5 + CCl 4 (3.28 ± 0.28%, P<0.001) and AITC50 + CCl 4 (2.68 ± 0.19%, P<0.001) groups showed significantly decreased areas of Sirius Red-positive collagen tissue compared with the liver tissue in the vehicle + CCl 4 group (Fig. 2E) .
Kupffer cell and inflammatory cell activity in the liver tissue of CCl 4 -intoxicated rats is an important indicator of liver toxicity [1] . To evaluate macrophage activity, we performed immunostaining with Iba-1 antibody. In the hepatic tissues of the vehicle + CCl 4 group, Iba-1-positive cells were markedly increased around the central vein (Fig. 3B ) compared with the normal control group (Fig. 3A) , and the intensity decreased with AITC treatment (Figs. 3C and 3D ). The Iba-1-positive area in the vehicle + CCl 4 group was significantly increased (17.80 ± 2.16%, P<0.001) compared with the normal control group. However, both the AITC5 + CCl 4 (12.18 ± 0.49%, P<0.001) and AITC50 + CCl 4 (11.39 ± 0.40%, P<0.001) groups showed significantly decreased areas compared to the vehicle + CCl 4 group (Fig. 3E) . Furthermore, the number of Iba-1-positive cells in the vehicle + CCl 4 group was significantly greater (70.73 ± 3.46, P<0.01) than that in the normal control group (13.33 ± 0.37). However, these numbers were significantly reduced in the AITC5 + CCl 4 (40.87 ± 5.16, P<0.05) and AITC50 + CCl 4 (41.60 ± 3.49, P<0.05) groups (Fig. 3F) .
In our previous study, we evaluated hepatoprotective effects, including the activation of antioxidant enzymes, radical scavenging, suppression of activated hepatic macrophages, and heme oxygenase-1 accumulation, in CCl 4 -induced acute liver injury [1] . In the present study, we confirmed the inhibitory effect of AITC, which is a metabolite of the glucosinolate sinigrin found in cruciferous vegetables (e.g., radish), against hepatic fibrosis, and its hepatoprotective effect (via antioxidant activity) against CCl 4 -induced liver injury. Serum AST and ALT levels, which are hepatotoxicity markers, decreased significantly in a dose-dependent manner in the AITC (5 and 50 mg/kg) + CCl 4 groups compared to the vehicle + CCl 4 group. Furthermore, the AITC + CCl 4 groups showed a reduction in hepatic damage, such as hydropic degeneration, vacuolar degeneration, infiltration of inflammatory cells, and disappearance of hepatocyte arrangement (Fig. 2) , based on the histopathological examination. These results suggested that hepatic tissue damage caused by CCl 4 -induced liver injury was alleviated by AITC. Kupffer cell and macrophage activation accompany CCl 4 -induced liver injury [1, 2, 8] and are detected by Iba-1 immunostaining [11] . In a previous study of acute CCl 4 liver injury, AITC pretreatment inhibited inflammatory responses, including by suppression of Kupffer cell and macrophage activation and reduction of pro-inflammatory cytokine expression [1] . In addition, AITC ameliorated mucosal inflammation in a dextran sulfate sodium-induced acute colitis model via a reduction in macrophage infiltration [3] . In the present study, we confirmed that AITC ameliorated Kupffer cell activation and the inflammatory response (e.g., macrophage infiltration) based on a decrease in Iba-1-postive area in the liver. This indicates that AITC also ameliorates the inflammatory response in CCl 4 -induced liver injury.
Hepatic fibrosis has been known to be associated with inflammation of liver [7] , which is also caused by repeated administration of CCl 4 in rats [2, 7] . Therefore, suppression of hepatic inflammation is pivotal to reduce the hepatic fibrosis. AITC has been known to ameliorate oxidative stress and fatty changes in a single CCl 4 -induced liver injury model [1] , and also to reduce fibrosis in carboxymethyl-lysine-treated hepatic stellate cells via the suppression of α-smooth muscle actin mRNA [10] . Collectively, these findings suggest that AITC treatment reduces fibrosis in the liver with repeated exposure of CCl 4 in rats. 
